DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform…
CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals…
NEW YORK, Aug. 19, 2024 /PRNewswire/ --The ABCSW, the national standard-setting organization focused on credentialing and professional development for practitioners of…
2024 Public Health Informatics Profile Highlights Need for Increased Investments to Expand Informatics Services to Improve Health WASHINGTON, Aug. 19,…
UNIVERSITY PARK, Pa. , Aug. 19, 2024 /PRNewswire/ -- TEAMology, an international leader in K-8 social-emotional support solutions, is thrilled to…
MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage…
Three months post cessation of an 8-week course of microdosing treatment, the antidepressant response is sustained with a 62.8% reduction…
TORRINGTON, Conn., Aug. 15, 2024 /PRNewswire/ -- Therap Services, the leading provider of electronic record and documentation services for agencies…
BERLIN, Germany, Aug. 15, 2024 /PRNewswire/ -- Clue, a leading menstrual and reproductive health tracking app, and Headspace, a leading…
Michael O'Neil details Get Well and Canopy Children's Solutions' mental health collaboration at the Aspen Institute's Resnick Aspen Action Forum…